1,023 research outputs found
Target mass number dependence of subthreshold antiproton production in proton-, deuteron- and alpha-particle-induced reactions
Data from KEK on subthreshold \bar{\mrm{p}} as well as on and
\mrm{K}^\pm production in proton-, deuteron- and -induced reactions
at energies between 2.0 and 12.0 A GeV for C, Cu and Pb targets are described
within a unified approach. We use a model which considers a nuclear reaction as
an incoherent sum over collisions of varying numbers of projectile and target
nucleons. It samples complete events and thus allows for the simultaneous
consideration of all final particles including the decay products of the
nuclear residues. The enormous enhancement of the \bar{\mrm{p}} cross
section, as well as the moderate increase of meson production in deuteron and
induced compared to proton-induced reactions, is well reproduced for
all target nuclei. In our approach, the observed enhancement near the
production threshold is mainly due to the contributions from the interactions
of few-nucleon clusters by simultaneously considering fragmentation processes
of the nuclear residues. The ability of the model to reproduce the target mass
dependence may be considered as a further proof of the validity of the cluster
concept.Comment: 9 pages, 4 figure
Characterization of pulmonary function in 10â18 year old patients with Duchenne muscular dystrophy
Pulmonary function loss in patients with Duchenne muscular dystrophy (DMD) is progressive and leads to pulmonary insufficiency. The purpose of this study in 10â18 year old patients with DMD is the assessment of the inter-correlation between pulmonary function tests (PFTs), their reliability and the association with the general disease stage measured by the Brooke score. Dynamic PFTs (peak expiratory flow [PEF], forced vital capacity [FVC], forced expiratory volume in one second [FEV1]) and maximum static airway pressures (MIP, MEP) were prospectively collected from 64 DMD patients enrolled in the DELOS trial (ClinicalTrials.gov, number NCT01027884). Baseline PEF percent predicted (PEF%p) was <80% and patients had stopped taking glucocorticoids at least 12 months prior to study start. At baseline PEF%p, FVC%p and FEV1%p correlated well with each other (Spearman's rho: PEF%pâFVC%p: 0.54; PEF%pâFEV1%p: 0.72; FVC%pâFEV1%p: 0.91). MIP%p and MEP%p correlated well with one another (MIP%pâMEP%p: 0.71) but less well with PEF%p (MIP%pâPEF%p: 0.40; MEP%pâPEF%p: 0.41) and slightly better with FVC%p (MIP%pâFVC%p: 0.59; MEP%pâFVC%p: 0.74). The within-subject coefficients of variation (CV) for successive measures were 6.97% for PEF%p, 6.69% for FVC%p and 11.11% for FEV1%p, indicating that these parameters could be more reliably assessed compared to maximum static airway pressures (CV for MIP%p: 18.00%; MEP%p: 15.73%). Yearly rates of PFT decline (placebo group) were larger in dynamic parameters (PEF%p: â8.9% [SD 2.0]; FVC%p: â8.7% [SD 1.1]; FEV1%p: â10.2% [SD 2.0]) than static airway pressures (MIP%p: â4.5 [SD 1.3]; MEP%p: â2.8 [SD 1.1]). A considerable drop in dynamic pulmonary function parameters was associated with loss of upper limb function (transition from Brooke score category 4 to category 5). In conclusion, these findings expand the understanding of the reliability, correlation and evolution of different pulmonary function measures in DMD patients who are in the pulmonary function decline phase
- …